Share
Kristine Ball
Kristine Ball as President & CEO of Antiva Biosciences, has joined the Board of Directors
Kristine Ball, who has a robust background in leadership roles within the life sciences industry, is currently President & CEO of Antiva Biosciences. Her experience spans finance, corporate strategy, and executive management, including previous roles as CEO of Soteria Biotherapeutics and CFO of Menlo Therapeutics. Her addition to the Board of Directors is expected to provide valuable guidance as Oruka advances its lead programs, ORKA-001 and ORKA-002, towards clinical trials.
